PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 25, 2026JAMA Network Open0 citationsOpen Access

Family Pharmacist System for Patients With Chronic Cardiovascular or Endocrine Disease

View Full Paper
RIRyo IketaniSIShinobu Imai

Key Points

  • To evaluate the impact of a family pharmacist system on mortality and hospitalization risks in patients with chronic cardiovascular or endocrine diseases.
  • Conducted a large-scale cohort study
  • Analyzed the effects of FPS on patient outcomes
  • Focused on patients with chronic cardiovascular or endocrine disease
  • FPS was not linked to a lower risk of death or hospitalization overall
  • Hypothesis emerged suggesting FPS use may reduce mortality risk in older patients with chronic conditions

Abstract

This large-scale cohort study found that the use of an FPS was not associated with lower risk of death or hospitalization from any cause. However, the results generated a clinically important hypothesis that FPS use may be associated with slightly lower risk of death among older patients with chronic cardiovascular or endocrine disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Iketani et al. (2026) studied this question.

synapsesocial.com/papers/699e9152f5123be5ed04ecfchttps://doi.org/10.1001/jamanetworkopen.2025.60398
Ask AI
Helpful
Bookmark
Share
View Full Paper